Results 181 to 190 of about 22,864 (242)
Some of the next articles are maybe not open access.

The role of incretins and incretin-based drugs in autoimmune diseases.

International Immunopharmacology, 2021
Incretin hormones, including glucagon-like peptide (GLP)-1, GLP-2 and glucose-dependent insulinotropic polypeptide (GIP), are gastrointestinal peptides secreted from enteroendocrine cells. These hormones play significant roles in many physiological processes via binding to G-protein coupled receptors (GPCRs) on different organs and tissues; one of them
Shabnam Radbakhsh   +3 more
semanticscholar   +3 more sources

Incretins and Lipid Metabolism.

Current Medicinal Chemistry, 2017
Background: Recent findings indicate that incretin hormones and incretin-based therapies may affect the metabolism of lipoproteins, although the corresponding mechanisms are not clearly defined. Objective: To summarize the available data on the mechanisms linking incretins with the characteristics of serum lipoproteins and discuss the clinical ...
V. Tsimihodimos, M. Elisaf
semanticscholar   +3 more sources

Incretins in obesity and diabetes

open access: yesAnnals of the New York Academy of Sciences, 2020
Incretins are hormones secreted from enteroendocrine cells after nutrient intake that stimulate insulin secretion from β cells in a glucose‐dependent manner.
Chee W Chia
exaly   +2 more sources

Incretins in the Therapy of Diabetic Kidney Disease

open access: yesInternational Journal of Molecular Sciences, 2021
Diabetic kidney disease is a microvascular complication that occurs in patients with diabetes. It is strongly associated with increased risk of kidney replacement therapy and all-cause mortality.
Agnieszka   +2 more
exaly   +2 more sources

The emerging role of incretins and twincretins

Nature Reviews Endocrinology, 2021
Elaine Chow, Juliana Chung-ngor Chan
exaly   +2 more sources

The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update

Diabetes, obesity and metabolism, 2021
The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion after their nutrient‐induced secretion from the gut.
M. Nauck   +3 more
semanticscholar   +1 more source

Potential Incretins

Mayo Clinic Proceedings, 1988
A greater plasma concentration of insulin after isoglycemic enteral than after parenteral administration of glucose is called the incretin effect. The primary mediator of this effect, gastric inhibitory polypeptide, may not account for the complete manifestation of this phenomenon.
L T, Shuster   +4 more
openaire   +2 more sources

Incretins: Their physiology and application in the treatment of diabetes mellitus

open access: yesDiabetes/Metabolism Research and Reviews, 2014
Mustafa Kemal Balci, Salih Sanlioglu
exaly   +2 more sources

Incretin hormones - an update

Scandinavian Journal of Clinical and Laboratory Investigation, 2001
Incretin hormones are insulinotropic hormones from the intestinal mucosa, which after being released in response to ingestion of a meal, enhance insulin secretion in excess of that elicited by the absorbed nutrients (glucose. amino acids etc) themselves.
Holst, J.J., Orskov, C.
openaire   +2 more sources

Home - About - Disclaimer - Privacy